Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Obinutuzumab in Chinese Patients With Indolent Non-Hodgkin's B-cell Lymphoma in the Real-World.
This study aims to assess the clinical efficacy and safety of obinutuzumab in Chinese patients with indolent non-Hodgkin B-cell Lymphoma (predominantly Follicular lymphoma and Marginal zone lymphoma) in a real-world setting.
This study was a prospective, multicenter, non-interventional, real-world study. The study will be divided into two cohorts: Cohort 1 is the younger cohort (aged ≥ 18 and \< 60 years at the start of treatment); Cohort 2 is the older cohort (aged ≥ 60 years at the start of treatment). Patients in this study will receive obinutuzumab-contained regimens according to the investigators' clinical opinion.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Changzhou No.2 People's Hospital
Changzhou, Jiangsu, China
The First People's hospital of Changzhou
Changzhou, Jiangsu, China
Huai'an First People's hospital
Huai'an, Jiangsu, China
Jiangyin People's Hospital
Jiangyin, Jiangsu, China
Jingjiang People's Hospital
Jingjiang, Jiangsu, China
The first people's hospital of Lianyungang
Lianyungang, Jiangsu, China
The second people's hospital of Lianyungang
Lianyungang, Jiangsu, China
Jiangsu Province Hospital of Chinese Medicine
Nanjing, Jiangsu, China
Jiangsu Province Hospital
Nanjing, Jiangsu, China
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
Start Date
July 20, 2023
Primary Completion Date
December 30, 2024
Completion Date
July 20, 2026
Last Updated
August 1, 2023
400
ESTIMATED participants
Obinutuzumab
DRUG
Lead Sponsor
Affiliated Hospital of Nantong University
NCT03244176
NCT03029338
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions